Photo of Mark J. Biagi

Mark J. Biagi


Clinical Assistant Professor, College of Pharmacy - Pharmacy Practice
Clinical Instructor, College of Pharmacy - Pharmacy Practice

Related Sites:

Teaching and Supervision

Undergrad Resrch Pharm Pract (PMPR 380), 1/11/2021 – 4/30/2021
PHAR 520: Clinical Pharmaceutics, Pharmacokinetics, and Pharmacogenomics (PHAR 520), 8/17/2020 – 12/11/2020
PHAR 435: Pharmacokinetics (PHAR 435), 8/26/2019 – 12/6/2019
Spec Project in Pharm Pract (PMPR 390), 8/26/2019 – 12/6/2019
Spec Project in Pharm Pract (PMPR 390), 8/26/2019 – 12/6/2019
Antimicrobial Use in Pregnancy, 2018 – 5/13/2020
Antimicrobial Dosing in Obesity, 2017 – 2018
Management of Antiretroviral Resistance, 2016 – 2016
Review of Psychotropic Medications, 2016 – 2016

Selected Grants

ACTIV-4c: COVID-19 Post-Hospital Thrombosis Prevention Study, National Institutes of Health., 4/1/2021 - Present, No Obligated Amount Set; No Anticipated Amount Set

Real World Multicenter Observational Study of Imipenem-Cilastatin-Relebactam for Gram-Negative Infections, Merck & Co., Inc.., 4/1/2021 - Present, No Obligated Amount Set; No Anticipated Amount Set

Multicenter Observational Study of Dalbavancin for Invasive Bloodstream Infections, Allergan Inc.., 4/1/2021 - Present, No Obligated Amount Set; No Anticipated Amount Set

ACTIV-4 ACUTE: COVID-19 Acute Inpatient Antithrombotic Study, National Institutes of Health., 10/1/2020 - Present, No Obligated Amount Set; No Anticipated Amount Set

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to those on Vancomycin and Ceftolozane-Tazobactam, Merck & Co.., 8/1/2020 - Present, No Obligated Amount Set; No Anticipated Amount Set

Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients, Merck Sharp & Dohme Corp., 3/1/2020 - 7/31/2022, No Obligated Amount Set; Anticipated Amount: $137232.72

Real-world experience with eravacycline at academic hospital systems, Tetraphase Pharmaceuticals., 2/1/2020 - Present, No Obligated Amount Set; No Anticipated Amount Set

Aztreonam + ceftazidime/avibactam against Stenotrophomonas maltophilia, Cystic Fibrosis Foundation., 6/1/2019 - 11/30/2020, Obligated Amount: $54000; Anticipated Amount: $54000

Evaluation of omadacycline activity against minocycline-susceptible and –resistant Acinetobacter baumannii, Paratek Pharmaceuticals., 5/2019 - 5/2019, No Obligated Amount Set; No Anticipated Amount Set

Selected Publications

Rebold, Nicholas, Morrisette, Taylor, Lagnf, Abdalhamid M, Alosaimy, Sara, Holger, Dana, Barber, Katie, Justo, Julie Ann, Antosz, Kayla, Carlson, Travis J, Frens, Jeremy J, Biagi, Mark, Kufel, Wesley D, Moore, William J, Mercuro, Nicholas, Raux, Brian R, Rybak, Michael J. (2021). Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open Forum Infectious Diseases, 8, (12), ofab554. doi:10.1093/ofid/ofab554.

Lee, Michelle, Abbey, Taylor, Biagi, Mark, Wenzler, Eric. (2021). Activity of aztreonam in combination with ceftazidime-avibactam against serine- and metallo-β-lactamase-producing Pseudomonas aeruginosa.. Diagnostic Microbiology and Infectious Disease, 99, (1). doi:10.1016/j.diagmicrobio.2020.115227.

Alosaimy, Sara, Lagnf, Abdalhamid M, Molina, Kyle, King, Madeline, Pullinger, Benjamin, Tart, Serina, Jones, Bruce M, Claeys, Kimberly C, Truong, James, Andrade, Justin A, Biagi, Mark, Pierce, Michael, Cosimi, Reese, Hobbs, Athena LV, Perkins, Nicholson, Huang, Glen, Veve, Michael, Morrisette, Taylor, Davis, Susan L, Davis, Susan L, Rybak, Michael J. (2020). 1577. Real-World, Multicenter Experience with Eravacycline for Various Infections. Open Forum Infectious Diseases, 7, (Suppl 1), s787-s787. doi:10.1093/ofid/ofaa439.1757.

Biagi, Mark, Slipke, Wendy, Smalley, Alexa, Tsaras, Geoffrey. (2020). Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole. International Journal of STD & AIDS, 32, (1), 89-91. doi:10.1177/0956462420963912.

Butler, David A, Biagi, Mark, Gupta, Vikas, Wieczorkiewicz, Sarah, Young, Lisa, Patel, Ursula, Naegele, Sandy, Santarossa, Maressa, Harrington, Amanda, Postelnick, Mike, Suseno, Mira, Christensen, Alyssa, Giddens, Julie, Murrey, Tim, Hanson, Amy, Sam, Sharon, Pettit, Natasha, Danziger, Larry, Wenzler, Eric. (2020). Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data. Infection Control and Hospital Epidemiology, 41, (12), 1409-1418. doi:10.1017/ice.2020.334.

Biagi, M, Vialichka, A, Jurkovic, M, Wu, T, Shajee, A, Lee, M, Patel, S, Mendes, RE, Wenzler, E. (2020). Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy, 64, (9), e00559-e00520. doi:10.1128/aac.00559-20.

Wenzler, E, Biagi, M, Tan, X, Butler, DA. (2020). Reply to Baud and Houzé, “Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?”. Antimicrobial Agents and Chemotherapy, 64, (6). doi:10.1128/aac.00401-20.

Biagi, M, Shajee, A, Vialichka, A, Jurkovic, M, Tan, X, Wenzler, E. (2020). Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.. Antimicrobial Agents and Chemotherapy, 64, (4). doi:10.1128/aac.02255-19.

Biagi, MJ, Schriever, CA, Chiampas, TD, Michienzi, SM, Patel, MC, Young, JD, Badowski, ME. (2020). Development of gynecomastia following initiation of bictegravir/emtricitabine/tenofovir alafenamide. International Journal of STD & AIDS, 31, (4), 380-382. doi:10.1177/0956462419895665.

Professional Leadership

Clostridioides difficile committee, SwedishAmerican Hospital, 2/1/2020 - Present

Education

Degrees:
Doctor of Pharmacy, University of Illinois at Chicago, United States, 2016
Bachelor of Science, University of Illinois at Chicago, United States, 2012

Postgraduate Training:
PGY-1 Pharmacy Practice Resident, Franciscan Health, United States, 2017

Selected Presentations

Biagi, Mark, Patel, Aakash. (2021 March 19). New drugs on the block: Combating Gram-negative resistance. Illinois Council of Health-System Pharmacists (ICHP) & Missouri Society of Health-System Pharmacists (MSHP) Spring Virtual Meeting.
Shajee, Aisha, Biagi, Mark. (2020 October 01). In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against imipenem-nonsusceptible Pseudomonas aeruginosa. Illinois Council of Health-System Pharmacists (ICHP) 2020 Annual Meeting. Oakbrook Terrace, IL.